Tag: Biotechnology

Eli Lilly launches program to help boost employer coverage of obesity drugs in U.S.

Novo Nordisk to slash GLP-1 list prices by up to 50% in U.S. to cut costs for insured patients

FDA chief warns U.S. is losing ground to China in early drug development, calls for faster trial approvals

FDA agrees to review Moderna’s mRNA flu vaccine application in a reversal

FDA chief Marty Makary says ‘everything should be over-the-counter’ unless drug is unsafe or addictive

Novo Nordisk faces a defining year in the obesity drug market. It’s off to a dramatic start

Novo Nordisk CEO sees 15 million-patient opportunity in Medicare coverage for obesity drugs

Moderna says FDA refuses to review its application for experimental flu shot

CVS tops quarterly estimates, reaffirms profit outlook as turnaround plan takes effect

Novo Nordisk sues Hims & Hers over cheaper copycat versions of Wegovy pill, injections